Float Short %

3.88

Margin Of Safety %

Put/Call OI Ratio

0.52

EPS Next Q Diff

EPS Last/This Y

0.51

EPS This/Next Y

0.22

Price

10.88

Target Price

24.38

Analyst Recom

1.12

Performance Q

-37.9

Relative Volume

Beta

1.1

Ticker: AXGN

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	AXGN	16.05	0.62	3.00	2571
2025-04-15	AXGN	15.65	0.62	0.30	2570
2025-04-16	AXGN	15.59	0.62	4.50	2578
2025-04-17	AXGN	15.57	0.45	0.00	2316
2025-04-18	AXGN	15.57	0.45	0.00	2316
2025-04-21	AXGN	15.19	0.96	0.03	828
2025-04-22	AXGN	15.42	0.92	0.00	848
2025-04-23	AXGN	15.61	0.89	0.00	865
2025-04-24	AXGN	16.18	0.81	0.00	911
2025-04-25	AXGN	16.4	0.78119001919386	2.2916666666667	928
2025-04-28	AXGN	16.18	0.91666666666667	0	1081
2025-04-29	AXGN	16.51	0.88	999.99	1105
2025-04-30	AXGN	16.26	0.88	999.99	1106
2025-05-01	AXGN	16.46	0.90	2.94	1116
2025-05-02	AXGN	17.11	1.03	0.48	1240
2025-05-05	AXGN	16.69	1.03	0.07	1258
2025-05-06	AXGN	16.4	1.01	999.99	1271
2025-05-07	AXGN	16.4	1.02	0.00	1275
2025-05-08	AXGN	12.57	1.01	0.30	1280
2025-05-09	AXGN	11.37	0.39	0.77	984
2025-05-12	AXGN	11.38	0.55	0.13	1898
2025-05-13	AXGN	10.89	0.52	9.13	1991
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	AXGN	16.06	126.7	-	0.28
2025-04-15	AXGN	15.65	126.7	-	0.28
2025-04-16	AXGN	15.59	126.7	-	0.28
2025-04-17	AXGN	15.57	126.7	-	0.28
2025-04-18	AXGN	15.57	126.7	-	0.28
2025-04-21	AXGN	15.15	126.7	-	0.28
2025-04-22	AXGN	15.43	126.7	-	0.28
2025-04-23	AXGN	15.62	126.7	-	0.28
2025-04-24	AXGN	16.17	126.7	-	0.28
2025-04-25	AXGN	16.40	126.7	-	0.28
2025-04-28	AXGN	16.18	126.7	-	0.28
2025-04-29	AXGN	16.51	126.7	-	0.28
2025-04-30	AXGN	16.24	126.7	-	0.28
2025-05-01	AXGN	16.46	126.7	-	0.28
2025-05-02	AXGN	17.13	126.7	-	0.28
2025-05-05	AXGN	16.75	126.7	-	0.28
2025-05-06	AXGN	16.39	126.7	-	0.28
2025-05-07	AXGN	16.39	126.7	-	0.28
2025-05-08	AXGN	12.57	126.7	-	0.28
2025-05-09	AXGN	11.36	56.0	-	0.28
2025-05-12	AXGN	11.39	56.0	-	0.28
2025-05-13	AXGN	10.88	56.0	-	0.28
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	AXGN	-0.79	-1.73	4.40
2025-04-15	AXGN	-0.79	-1.73	4.40
2025-04-16	AXGN	-0.79	-1.73	4.40
2025-04-17	AXGN	-0.79	-1.73	4.40
2025-04-18	AXGN	-0.79	-1.73	4.40
2025-04-21	AXGN	-0.79	-0.14	4.40
2025-04-22	AXGN	-0.79	-0.14	4.40
2025-04-23	AXGN	-0.79	-0.14	4.40
2025-04-24	AXGN	-0.79	-0.14	4.40
2025-04-25	AXGN	-0.79	-0.14	4.40
2025-04-28	AXGN	-0.79	0.13	4.62
2025-04-29	AXGN	-0.79	0.13	4.62
2025-04-30	AXGN	-0.79	0.13	4.62
2025-05-01	AXGN	-0.79	0.13	4.62
2025-05-02	AXGN	-0.79	0.13	4.62
2025-05-05	AXGN	-0.79	0.32	4.62
2025-05-06	AXGN	-0.79	0.32	4.62
2025-05-07	AXGN	-0.77	0.32	4.50
2025-05-08	AXGN	-0.77	0.32	4.50
2025-05-09	AXGN	-0.77	0.32	4.50
2025-05-12	AXGN	-0.77	-2.12	3.88
2025-05-13	AXGN	-0.77	-2.12	3.88
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.08

Avg. EPS Est. Next Quarter

0.08

Insider Transactions

-0.77

Institutional Transactions

-2.12

Beta

1.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

12.97

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

54.6

Max Drawdown 5-Year %

-84.6

Target Price

24.38

P/E

Forward P/E

22.91

PEG

P/S

2.55

P/B

4.7

P/Free Cash Flow

416.41

EPS

-0.16

Average EPS Est. Cur. Y

0.28

EPS Next Y. (Est.)

0.51

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.68

Relative Volume

Return on Equity vs Sector %

-33.3

Return on Equity vs Industry %

-27.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

AxoGen, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 451

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.

stock quote shares AXGN – AxoGen, Inc. Stock Price stock today

news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AXGN – AxoGen, Inc. yahoo finance google finance

stock history AXGN – AxoGen, Inc. invest stock market

stock prices AXGN premarket after hours

ticker AXGN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AXGN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y